AKERO THERAPEUTICS INC (AKRO)
US00973Y1082 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -237.22M | -151.76M | -112.03M | -100.78M | -79.21M | |||
| Depreciation Amortization | 2.00K | 29.00K | 40.00K | 40.00K | 20.00K | |||
| Change In Working Capital | 8.32M | -6.67M | -4.46M | 9.73M | 2.09M | |||
| Interest Paid | 3.71M | 2.48M | 440.00K | N/A | N/A | |||
| Other non cash items | 17.26M | 13.03M | 23.93M | 11.33M | 6.30M | |||
| OPERATING CASH FLOW | -211.64M | -145.37M | -92.52M | -79.68M | -70.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -150.00K | |||
| Other Investing Activity | -111.19M | -223.62M | -63.83M | 42.28M | -9.61M | |||
| INVESTING CASH FLOW | -112.19M | -223.62M | -63.83M | 42.28M | -9.76M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.00M | 15.00M | 9.61M | N/A | N/A | |||
| Stock Issued/Repurchased | 361.20M | 339.09M | 246.50M | 1.12M | 203.06M | |||
| Other Financing Activity | -841.00K | -776.00K | -470.00K | -520.00K | 50.00K | |||
| FINANCING CASH FLOW | 370.36M | 353.32M | 255.63M | 600.00K | 203.11M | |||
| CHANGE IN CASH | 46.52M | -15.67M | 99.28M | -36.80M | 122.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -211.64M | -145.37M | -92.52M | -79.68M | -70.80M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -150.00K | |||
| FREE CASH FLOW | -212.64M | -145.37M | -92.52M | -79.68M | -70.95M | |||
All data in USD